Registration provision for biological products to be consolidated.

The health registration process for the biological and genetic recombinant drugs will be integrated and put under the single provisional control.

The KFDA will disclose the intent of revising and consolidating all health registration provisions for the manufacture and import of pharmaceutical and quasi-drug preparations, and the registration and clinical study guidelines for the biological, ...